Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis

Clinical Endocrinology

Volumn 74, Issue 6, 2011, Pages 699-704

  Chung, Ho Yeon ^a   Chin, Sang Ouk ^a   Kang, Moo Il ^b   Koh, Jung Min ^c   Moon, Sung Hwan ^d   Yoon, Byung Koo ^e   Yoon, Hyun Koo ^f   Chung, Yoon Sok ^g   Park, Hyoung Moo ^h  

^a Kyung Hee University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c University of Ulsan   (South Korea)

^d Yonsei University   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Catholic Kwandong University   (South Korea)

^g Ajou University   (South Korea)

^h Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL DERIVATIVE; COLECALCIFEROL PLUS RISEDRONIC ACID; PARATHYROID HORMONE; RISEDRONIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE TURNOVER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; FUNCTION TEST; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; KIDNEY DYSFUNCTION; KOREA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MUSCLE FUNCTION; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

AGED; ALKALINE PHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; KOREA; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; PEPTIDES; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; TREATMENT OUTCOME; VITAMIN D;

EID: 79955841644     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04041.x     Document Type: Article

References (23)

1. Anonymous. (2010) Physicians guide to the prevention and treatment of osteoporosis.
2. Anonymous. (2010) Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause, 17, 25-54.
3. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. American Journal of Clinical Nutrition, 84, 18-28. (Pubitemid 44699167)
4. Holick, M.F., (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings, 81, 353-373. (Pubitemid 43334631)
5. Lee, M.K., Yim, S., Lee, E.S., et al. (2007) Vitamin D perception gap survey between postmenopausal women with osteoporosis and physicians. Korean Journal of Bone Metabolism, 14, 133-139.
6. Recker, R., Lips, P., Felsenberg, D., et al. (2006) Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Current Medical Research Opinion, 22, 1745-1755. (Pubitemid 44449231)
7. Ross, A.C., Manson, J.E., Abrams, S.A., et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Instute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism, 96, 53-58.
8. Holick, M.F., (2007) Vitamin D deficiency. New England Journal of Medicine, 357, 266-281.
9. Guralnik, J.M., Ferrucci, L., Simonsick, E.M., et al. (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. New England Journal of Medicine, 332, 556-561.
10. Harris, S.T., Watts, N.B., Genant, H.K., et al. (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. The Journal of American Medical Association, 282, 1344-1352. (Pubitemid 29483192)
11. McClung, M.R., Geusens, P., Miller, P., et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. New England Journal of Medicine, 344, 333-340. (Pubitemid 32107641)
12. Bischoff-Ferrari, H.A., Stahelin, H.B., Dick, W., et al. (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. Journal of Bone and Mineral Research, 18, 343-351. (Pubitemid 36125927)
13. Holick, M.F., Siris, E.S., Binkley, N., et al. (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology and Metabolism, 90, 3215-3224. (Pubitemid 41014278)
14. Lips, P., Hosking, D., Lippuner, K., et al. (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. Journal of Internal Medicine, 260, 245-254. (Pubitemid 44253638)
15. Park, H.M., Kim, J.G., Choi, W.H., et al. (2003) The vitamin D nutritional status of postmenopausal women in Korea. Korean Journal of Bone Metabolism, 10, 47-55.
16. Watts, N.B., Bilezikian, J.P., Camacho, P.M., et al. (2010) American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocrine Practice, 16 (Suppl 3), 1-37.
17. Heckman, G.A., Papaioannou, A., Sebaldt, R.J., et al. (2002) Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. BMC Musculoskeletal Disorders, 3, 1-6. (Pubitemid 38994420)
18. Bayly, J.R., Holland, R.D., Riordan-Jones, S.E., et al. (2006) Prescribed vitamin D and calcium preparations in patients treated with bone remodeling agents in primary care: a report of a pilot study. Current Medical Research Opinion, 22, 131-137. (Pubitemid 43106916)
19. National Osteoporosis Foundation. (2010) Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, DC.
20. Binkley, N., Ringe, J.D., Reed, J.I., et al. (2009) Alendronate/vitamin D 70 mg/2800 IU with and without additional 2800 IU vitamin D for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial. Bone, 44, 639-647.
21. Pfeifer, M., Begerow, B., Minne, H.W., et al. (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Experimental and Clinical Endocrinology and Diabetes, 109, 87-92. (Pubitemid 32294575)
22. Bischoff-Ferrari, H.A., Dietrich, T., Orav, E.J., et al. (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function n both active and inactive persons aged ≤yen; 60 y. American Journal of Clinical Nutrition, 80, 752-758. (Pubitemid 41115542)
23. Iannuzzi-Sucich, M., Prestwood, K.M., &, Kenny, A.M., (2002) Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. The Journals of Gerontology, Series A, Biological Sciences and Medical Sciences, 57, M772-M777. (Pubitemid 35470952)